Advertisement
Screener

IOVANCE BIOTHERAPEUTICS, INC. (IOVA) Amortization of Debt Discount (Premium)

2.3 / 5 stars · 27/60 Roast Me

IOVANCE BIOTHERAPEUTICS, INC. Amortization of Debt Discount (Premium)

IOVANCE BIOTHERAPEUTICS, INC. (IOVA) reported Amortization of Debt Discount (Premium) of $6.01 million for the 12-month period ending 2021-12-31, per its 10-K filed 2022-02-24.

Discontinued › Cash Flow › Operating Activities

us-gaap:AmortizationOfDebtDiscountPremium · last filed 2022-02-24

  • IOVANCE BIOTHERAPEUTICS, INC. amortization of debt discount (premium) for the quarter ending 2021-12-31 was $836.00K, a 44.49% decline year-over-year.
  • IOVANCE BIOTHERAPEUTICS, INC. amortization of debt discount (premium) for the quarter ending 2021-09-30 was $1.31M, a 249.73% increase year-over-year.
  • IOVANCE BIOTHERAPEUTICS, INC. amortization of debt discount (premium) for the quarter ending 2021-06-30 was $1.80M, a 5342.42% increase year-over-year.
  • IOVANCE BIOTHERAPEUTICS, INC. amortization of debt discount (premium) for the quarter ending 2021-03-31 was $2.07M.
  • IOVANCE BIOTHERAPEUTICS, INC. amortization of debt discount (premium) for fiscal 2021 was $6.01M, a 222.41% increase from fiscal 2020.
  • IOVANCE BIOTHERAPEUTICS, INC. amortization of debt discount (premium) for fiscal 2020 was $1.86M.
  • IOVANCE BIOTHERAPEUTICS, INC. amortization of debt discount (premium) for fiscal 2019 was -$3.42M.
  • IOVANCE BIOTHERAPEUTICS, INC. amortization of debt discount (premium) for fiscal 2018 was -$1.33M, a 7110.53% decline from fiscal 2017.
Period endAmortization of Debt Discount (Premium) 3 monthAmortization of Debt Discount (Premium) 3 month as first filedAmortization of Debt Discount (Premium) 6 monthAmortization of Debt Discount (Premium) 9 monthAmortization of Debt Discount (Premium) 9 month as first filedAmortization of Debt Discount (Premium) 12 monthAmortization of Debt Discount (Premium) 48 monthAmortization of Debt Discount (Premium) 51 monthAmortization of Debt Discount (Premium) 54 monthAmortization of Debt Discount (Premium) 57 monthAmortization of Debt Discount (Premium) 60 monthAmortization of Debt Discount (Premium) 63 monthAmortization of Debt Discount (Premium) 66 monthAmortization of Debt Discount (Premium) 69 monthAmortization of Debt Discount (Premium) 72 monthAmortization of Debt Discount (Premium) 78 month
2021-12-31$836.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24
$2.15M
derived: sum of 2 quarters · filed 2022-02-24
$3.95M
derived: sum of 3 quarters · filed 2022-02-24
$6.01M
10-K · filed 2022-02-24
2021-09-30$1.31M
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04
$3.11M
derived: sum of 2 quarters · filed 2021-11-04
$5.18M
10-Q · filed 2021-11-04
$6.68M
derived: sum of 4 quarters · filed 2022-02-24
2021-06-30$1.80M
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05
$3.86M
10-Q · filed 2021-08-05
$5.37M
derived: sum of 3 quarters · filed 2022-02-24
$5.74M
derived: sum of 4 quarters · filed 2022-02-24
2021-03-31$2.07M
10-Q · filed 2021-05-06
$3.57M
derived: sum of 2 quarters · filed 2022-02-24
$3.95M
derived: sum of 3 quarters · filed 2022-02-24
$3.98M
derived: sum of 4 quarters · filed 2022-02-24
2020-12-31$1.51M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24
$1.88M
derived: sum of 2 quarters · filed 2022-02-24
$1.92M
derived: sum of 3 quarters · filed 2022-02-24
$1.86M
10-K · filed 2022-02-24
2020-09-30$376.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04
$409.00K
derived: sum of 2 quarters · filed 2021-11-04
$359.00K
10-Q · filed 2021-11-04
-$27.00K
derived: sum of 4 quarters · filed 2022-02-24
2020-06-30$33.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05
-$17.00K
10-Q · filed 2021-08-05
-$403.00K
derived: sum of 3 quarters · filed 2022-02-24
-$1.01M
derived: sum of 4 quarters · filed 2022-02-24
2020-03-31-$50.00K
10-Q · filed 2021-05-06
-$436.00K
derived: sum of 2 quarters · filed 2022-02-24
-$1.04M
derived: sum of 3 quarters · filed 2022-02-24
-$2.24M
derived: sum of 4 quarters · filed 2022-02-24
2019-12-31-$386.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24
-$991.00K
derived: sum of 2 quarters · filed 2022-02-24
-$2.19M
derived: sum of 3 quarters · filed 2022-02-24
-$3.42M
10-K · filed 2022-02-24
2019-09-30-$605.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05
-$1.80M
derived: sum of 2 quarters · filed 2020-11-05
-$3.04M
10-Q · filed 2020-11-05
-$3.98M
derived: sum of 4 quarters · filed 2021-02-25
2019-06-30-$1.20M
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06
-$2.43M
10-Q · filed 2020-08-06
-$3.37M
derived: sum of 3 quarters · filed 2021-02-25
-$3.76M
derived: sum of 4 quarters · filed 2021-02-25
2019-03-31-$1.23M
10-Q · filed 2020-05-05
-$2.18M
derived: sum of 2 quarters · filed 2021-02-25
-$2.56M
derived: sum of 3 quarters · filed 2021-02-25
-$2.56M
derived: sum of 4 quarters · filed 2021-02-25
2018-12-31-$944.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25
-$1.33M
derived: sum of 2 quarters · filed 2021-02-25
-$1.33M
derived: sum of 3 quarters · filed 2021-02-25
-$1.33M
10-K · filed 2021-02-25
2018-09-30-$387.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-04
-$388.00K
derived: sum of 2 quarters · filed 2019-11-04
-$388.00K
10-Q · filed 2019-11-04
-$388.00K
derived: sum of 4 quarters · filed 2020-02-25
2018-06-30-$1.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-01
-$1.00K
10-Q · filed 2019-08-01
-$1.00K
derived: sum of 3 quarters · filed 2020-02-25
-$19.00K
derived: sum of 4 quarters · filed 2020-02-25
2018-03-31$0.00
10-Q · filed 2019-05-07
$0.00
derived: sum of 2 quarters · filed 2020-02-25
-$18.00K
derived: sum of 3 quarters · filed 2020-02-25
-$9.00K
derived: sum of 4 quarters · filed 2020-02-25
2017-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25
-$18.00K
derived: sum of 2 quarters · filed 2020-02-25
-$9.00K
derived: sum of 3 quarters · filed 2020-02-25
$19.00K
10-K · filed 2020-02-25
2017-09-30-$18.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-06
-$9.00K
derived: sum of 2 quarters · filed 2018-11-06
$19.00K
10-Q · filed 2018-11-06
$14.00K
derived: sum of 4 quarters · filed 2019-02-28
2017-06-30$9.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-07
$37.00K
10-Q · filed 2018-08-07
$32.00K
derived: sum of 3 quarters · filed 2019-02-28
-$37.00K
derived: sum of 4 quarters · filed 2019-02-28
2017-03-31$28.00K
10-Q · filed 2018-05-10
$23.00K
derived: sum of 2 quarters · filed 2019-02-28
-$46.00K
derived: sum of 3 quarters · filed 2019-02-28
-$46.00K
derived: sum of 4 quarters · filed 2019-02-28
2016-12-31-$5.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-28
-$74.00K
derived: sum of 2 quarters · filed 2019-02-28
-$74.00K
derived: sum of 3 quarters · filed 2019-02-28
-$74.00K
10-K · filed 2019-02-28
2016-09-30-$69.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-02
-$69.00K
derived: sum of 2 quarters · filed 2017-11-02
-$69.00K
10-Q · filed 2017-11-02
2016-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-03
$0.00
10-Q · filed 2017-08-03
2016-03-31$0.00
10-Q · filed 2017-05-03
2015-12-31$0.00
10-K · filed 2018-03-12
2014-03-31$5.50M
10-Q · filed 2014-05-14
2013-12-31$0.00
derived: 10-K 12 month − 3 quarters · filed 2014-03-28
$0.00
derived: sum of 2 quarters · filed 2014-03-28
$0.00
derived: sum of 3 quarters · filed 2014-03-28
$0.00
10-K · filed 2014-03-28
$5.50M
10-K · filed 2014-03-28
2013-09-30$0.00
derived: 10-Q 72 month − 10-Q 69 month · filed 2013-11-14
$0.00
derived: sum of 2 quarters · filed 2013-11-14
$0.00
derived: sum of 3 quarters · filed 2013-11-14
$0.00
derived: sum of 4 quarters · filed 2014-03-28
$5.50M
10-Q · filed 2013-11-14
2013-06-30$0.00
derived: 10-Q 69 month − 10-Q 66 month · filed 2013-10-23
$0.00
derived: sum of 2 quarters · filed 2013-10-23
$0.00
derived: sum of 3 quarters · filed 2014-03-28
$0.00
derived: sum of 4 quarters · filed 2014-03-28
$5.50M
10-Q · filed 2013-10-23
2013-03-31$0.00
10-Q · filed 2013-10-23
$0.00
derived: sum of 2 quarters · filed 2014-03-28
$0.00
derived: sum of 3 quarters · filed 2014-03-28
$497.89K
derived: sum of 4 quarters · filed 2014-03-28
$5.50M
10-Q · filed 2013-10-23
2012-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-28
$0.00
derived: sum of 2 quarters · filed 2014-03-28
$497.89K
derived: sum of 3 quarters · filed 2014-03-28
$497.89K
10-K · filed 2014-03-28
$5.50M
10-K · filed 2013-09-23
2012-09-30$0.00
10-Q · filed 2013-01-25
$497.89K
derived: sum of 2 quarters · filed 2013-10-23
$497.89K
10-Q · filed 2013-11-14
$2.90M
derived: sum of 4 quarters · filed 2013-10-23
$5.50M
10-Q · filed 2013-01-25
2012-06-30$497.89K
10-Q · filed 2013-10-23
$497.89K
10-Q · filed 2013-10-23
$2.90M
derived: sum of 3 quarters · filed 2013-10-23
$5.50M
derived: sum of 4 quarters · filed 2013-10-23
$5.50M
10-Q/A · filed 2012-09-10
2012-03-31$0.00
10-Q · filed 2013-10-23
$2.40M
derived: sum of 2 quarters · filed 2013-10-23
$5.00M
derived: sum of 3 quarters · filed 2013-10-23
$5.00M
10-Q · filed 2012-05-15
2011-12-31$2.40M
derived: 10-K 12 month − 10-Q 9 month · filed 2013-09-23
$5.00M
derived: sum of 2 quarters · filed 2013-09-23
$5.00M
10-K · filed 2013-09-23
$5.00M
10-K · filed 2012-03-30
2011-09-30$2.60M
10-Q · filed 2013-01-25
-$2.60M
10-Q · filed 2011-11-21
$2.60M
10-Q · filed 2013-01-25
-$2.60M
10-Q · filed 2011-11-21
-$2.60M
10-Q · filed 2011-11-21
2011-03-31$0.00
10-Q · filed 2012-05-15
$0.00
derived: sum of 2 quarters · filed 2012-05-15
$0.00
derived: sum of 3 quarters · filed 2012-05-15
2010-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-30
$0.00
derived: sum of 2 quarters · filed 2012-03-30
$0.00
10-K · filed 2012-03-30
2010-09-30$0.00
10-Q · filed 2011-11-21
$0.00
10-Q · filed 2011-11-21
2009-12-31$0.00
10-K · filed 2012-03-30

Similar stocks

Stock NameCountryMarket CapPE Ratio
Adaptive Biotechnologies Corp (ADPT)United States$4.719B-53.43
CRISPR Therapeutics AG (CRSP)$5.390B-11.68
Relay Therapeutics, Inc. (RLAY)United States$3.884B-14.30
Scholar Rock Holding Corp (SRRK)United States$5.920B-16.37
CG Oncology, Inc. (CGON)United States$6.095B-27.95
Tarsus Pharmaceuticals, Inc. (TARS)United States$3.329B-58.60
Denali Therapeutics Inc. (DNLI)United States$3.274B-8.04
Immunovant, Inc. (IMVT)United States$7.028B-14.78
Beam Therapeutics Inc. (BEAM)United States$2.549B-41.51
Greenland Mines Ltd (GRML)United States$2.362B